Bio SB - Cancer Diagnostics - production, distribution and marketing of unique products for Immunohistochemistry (IHC),http://pageoverview.com/website-report/biosb.com
Bio SB performs R&D, production, distribution and marketing of unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Fluorescent in situ hybridization (FISH), Chromogenic in situ hybridization (CISH), Liquid-Based Cytology (LBC) and Polymerase Chain Reaction (PCR) technologies that meet the highest international standards for applications in Molecular Pathology, Cancer Research, Microbiology, Immunology and Genetics. BIO SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP.
- Expected expiration: June 26th in 2021
- Creation date: June 26th in 1999
- Renew date: March 12th in 2016
- Google Analytics: 60691618-1